Kinases substrate binding

Left side of Fig. 4 shows a ribbon model of the catalytic (C-) subunit of the mammalian cAMP-dependent protein kinase. This was the first protein kinase whose structure was determined [35]. Figure 4 includes also a ribbon model of the peptide substrate, and ATP (stick representation) with two manganese ions (CPK representation). All kinetic evidence is consistent with a preferred ordered mechanism of catalysis with ATP binding proceeding substrate binding. 

Figure 5.9 Models of hexo-kinase in space-filling and wireframe formats, showing the cleft that contains the active site where substrate binding and reaction catalysis occur. At the bottom is an X-ray crystal structure of the enzyme active site, showing the positions of both glucose and ADP as well as a lysine amino acid that acts as a base to deprotonate glucose.

Tyrosine phosphorylated IRS interacts with and activates PI 3-kinase [3]. Binding takes place via the SRC homology 2 (SH2) domain of the PI 3-kinase regulatory subunit. The resulting complex consisting of INSR, IRS, and PI 3-kinase facilitates interaction of the activated PI 3-kinase catalytic subunit with the phospholipid substrates in the plasma membrane. Generation of PI 3-phosphates in the plasma membrane reemits phospholipid dependent kinases (PDKl and PDK2) which subsequently phosphorylate and activate the serine/threonine kinase Akt (synonym protein... 

KCOs binding site and a substrate-binding site. Protein kinases... 

Fig. 6. Vectorial phosphorylation by a mechanism in which translocation and phosphorylation of the sugar are two distinct steps. The product binding site of the translocator T (domain C of II ") would be the substrate binding site of the kinase K (domains A and B). Since both the left-hand cycle and the right-hand cycle are catalyzed by the same enzyme they will very likely be kinetically dependent. Note that the kinetic cycle on the left-hand side of the figure is identical to Fig. 5.

Leyton, L., and Saling, P. (1989). 95 kd sperm proteins bind ZP3 and serve as tyrosine kinase substrates in response to zona binding. Cell 57 1123-1130. 

Proteins from cDNA libraries are used for measurement of kinase substrate specificity and identification of phospholipid-binding proteins. 

It was initially argued that the best potential PTK inhibitors would be compounds that compete for the substrate in the kinase binding domain. It was argued that such compounds would be less toxic than ATP mimics since they bind to those domains at the kinase site that are less conserved than the substrate binding domains. Indeed tyrphostins like AG 490 which blocks Jak-2 [10] and AG 556 which possesses anti-inflammatory properties have been shown to be highly non-toxic in vivo [34-37]. 

Fig. 2. An example of a complex multidomain protein that includes both domain concatenation and intercalation. (A) See color insert. RASMOL view of phosphotransferase pyruvate kinase (pdb entry lpkn) colored to show the three identifiable domains. Blue is the j3 barrel regulatory domain, orange is an eightfold a/fi barrel, the catalytic substrate binding domain, and green is a central /3, a/(B nucleotide binding domain. Not displayed is the leader subsequence composed of a random coil and short helix. (B) Linear order along the sequence of these components.

Because many cells maintain ATP, ADP, and AMP concentrations at or near the mass action ratio of the adenylate kinase reaction, the cellular content of this enzyme is often quite high. A consequence of such abundance is that, even after extensive purification, many proteins and enzymes contain traces of adenylate kinase activity. The presence of this kinase can confound the quantitative analysis of processes that either require ADP or are carried out in the presence of both ATP and AMP. Furthermore, the equilibrium of any reaction producing ADP may be altered if adenylate kinase activity is present. To minimize the effect of adenylate kinase, one can utilize the bisubstrate geometrical analogues Ap4A and ApsA to occupy simultaneously both substrate binding pockets of this kinase . Typical inhibitory concentrations are 0.4 and 0.2 mM, respectively. Of course, as is the case for the use of any inhibitor, one must always determine whether Ap4A or ApsA has a direct effect on a particular reaction under examination. For example. Powers et al studied the effect of a series of o ,co-di-(adenosine 5 )-polyphosphates (e.g., ApnA, where n =... 

---